Echo Street Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Echo Street Capital Management’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,142	Closed	-$932K	–	572
2023 Q2	$932K	Buy	+8,142	New	+$1.05M	0.01%	149
2023 Q1	–	Sell	-7,075	Closed	-$917K	–	591
2022 Q4	$917K	Buy	+7,075	New	+$820K	0.01%	168
2022 Q2	–	Sell	-15,958	Closed	-$1.25M	–	700
2022 Q1	$1.25M	Buy	15,958 +2,156	+16%	+$165K	0.01%	189
2021 Q4	$1.24M	Buy	13,802 +6,690	+94%	+$572K	0.01%	206
2021 Q3	$658K	Buy	7,112 +4,289	+152%	+$330K	﹤0.01%	349
2021 Q2	$219K	Sell	2,823 -7,514	-73%	-$570K	﹤0.01%	543
2021 Q1	$770K	Buy	+10,337	New	+$954K	0.01%	211

Other funds holding SRPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Echo Street Capital Management's SRPT Position: Q3 2023 in Review

Echo Street Capital Management sold out of Sarepta Therapeutics (SRPT) in Q3 2023, closing a stake of 8,142 shares — an estimated $932K sold.

Echo Street Capital Management first reported a position in SRPT in Q1 2021 and held it in 7 quarters. The position peaked at $1.25M in Q1 2022. 395 funds tracked by Wall St. Rank hold SRPT as of Q3 2023.

Echo Street Capital Management reported no remaining Sarepta Therapeutics position as of Q3 2023 after selling out during the quarter.
Echo Street Capital Management sold 8,142 Sarepta Therapeutics shares in Q3 2023, an estimated $932K.
Echo Street Capital Management first reported a position in Sarepta Therapeutics in Q1 2021 and held it in 7 quarters.
Echo Street Capital Management's Sarepta Therapeutics position peaked at $1.25M in Q1 2022.
395 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2023.

Based on Echo Street Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.